This synthetic biology company manufactures recombinant collagen and high-value proteins at scale, utilizing advanced fermentation techniques to produce research-grade collagens with market-leading specifications. By providing cost-effective, pure collagen products, the company supports the growing demand for collagen-based biotechnologies in medical and research applications.
Funding
$400K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Traditional methods of sourcing collagen often result in inconsistent properties between batches due to damage during animal tissue extraction, leading to unreliable performance in applications such as cell therapy, wound healing, and tissue engineering. Furthermore, animal-derived collagens carry the risk of transmitting animal diseases.
Solution
ProColl is a synthetic biology company that addresses these issues by manufacturing both bovine and animal-free recombinant human collagens with consistent properties at scale. Their tightly controlled fermentation process ensures a high degree of consistency in molecular weights and functionality across batches. The recombinant human collagens offer high biocompatibility and native structure due to well-understood and implemented post-translational modifications. ProColl's process avoids harsh solvents and enzymes, ensuring protein structure is retained, making the material well-suited for cellular growth in vitro and in vivo, as well as for prototype medical device applications. The animal-free system also eliminates the risk of animal disease transmission.
Target Audience
ProColl serves companies in fields ranging from cell therapy, regenerative medicine, and aesthetics to food & beverage, as well as academic researchers seeking reliable collagen for research purposes.
Features
- Production of both bovine and recombinant human (animal-free) collagens
- Available in full-chain or single-chain formats
- Tightly controlled manufacturing process for batch-to-batch consistency
- High purity (≥ 95%) Type I acid soluble collagen derived from certified bovine sources
- Recombinant human collagens with implemented post-translational modifications for native human structure
- Manufacturing process avoids harsh solvents and enzymes to retain protein structure
- Suitable for cell culture, plate coating, hydrogels, scaffolds, and 3D bioprinting
- Available in liquid and solid formats